
IQVIA Holdings IQV
$ 229.99
-2.33%
Quarterly report 2025-Q2
added 07-22-2025
IQVIA Holdings EV/EBITDA Ratio 2011-2026 | IQV
Annual EV/EBITDA Ratio IQVIA Holdings
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 24.1 | 21.6 | 20.2 | 18.5 | 17.5 | 15.4 | 11.1 | 12.7 | 12.3 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 24.1 | 11.1 | 17 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Anixa Biosciences
ANIX
|
-2.25 | $ 3.01 | -2.9 % | $ 97.7 K | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 38.55 | -1.56 % | $ 1.07 B | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Brainsway Ltd.
BWAY
|
-43.6 | $ 23.6 | -1.87 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 33.99 | 1.34 % | $ 366 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | $ 102.46 | 0.15 % | $ 19 B | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 26.04 | -0.78 % | $ 787 M | ||
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.43 | -3.06 % | $ 1.82 M | ||
|
Guardant Health
GH
|
-28.8 | $ 111.67 | 1.08 % | $ 13.7 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
3.62 | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
20.1 | $ 219.24 | -0.1 % | $ 160 B | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 65.81 | -1.3 % | $ 4.55 B | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
DexCom
DXCM
|
39.5 | $ 73.07 | -1.26 % | $ 28.2 B | ||
|
CareDx, Inc
CDNA
|
-100 | $ 20.32 | -2.31 % | $ 1.09 B | ||
|
NeoGenomics
NEO
|
-33.5 | $ 11.84 | -4.52 % | $ 1.5 B | ||
|
Celcuity
CELC
|
-2.38 | $ 109.58 | -2.27 % | $ 4.32 B | ||
|
DarioHealth Corp.
DRIO
|
-1.05 | $ 11.0 | 6.8 % | $ 312 M | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Personalis
PSNL
|
-7.07 | $ 9.31 | -6.62 % | $ 552 M | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
70.5 | $ 145.86 | -2.56 % | $ 23.2 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Charles River Laboratories International
CRL
|
22 | $ 210.32 | -0.64 % | $ 10.8 B | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 581.3 | -1.83 % | $ 222 B | ||
|
Trinity Biotech plc
TRIB
|
12.6 | $ 0.84 | -5.23 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 39.99 | -3.82 % | $ 2.39 B | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 582.34 | -1.81 % | $ 18 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 184.75 | 1.32 % | $ 20.5 B | ||
|
Biodesix
BDSX
|
-4.25 | $ 8.9 | -7.92 % | $ 1.15 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
-1.8 | $ 24.39 | 0.54 % | $ 31.7 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 269.85 | 0.01 % | $ 22.6 B | ||
|
Mettler-Toledo International
MTD
|
827 | $ 1 386.62 | -0.44 % | $ 29.4 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 178.39 | -4.03 % | $ 14.7 B | ||
|
IDEXX Laboratories
IDXX
|
45.3 | $ 673.89 | -0.42 % | $ 55.6 B |